Global Erlotinib Generics Market Growth Driven by Rising NSCLC...

a adăugat un sunet Otro

2026-04-17 07:34:35 - Translate

Global Erlotinib Generics Market Growth Driven by Rising NSCLC Cases and Expanding Generic Drug Access to 2034

According to a new report from Intel Market Research, the global Erlotinib Generics market was valued at USD 682.4 million in 2025 and is projected to reach USD 1,189.3 million by 2034, growing at a robust CAGR of 6.4% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-small cell lung cancer, increasing healthcare expenditure in emerging...

0 Commentarii 0 Distribuiri 13 Views 0 previzualizare